Connect your AI

DENTSPLY SIRONA XRAY Increase (Decrease) in Accounts and Notes Receivable

Increase (Decrease) in Accounts and Notes Receivable at other companies

PepsiCoPEP

$530M+66.7%

CignaCI

-$2.15B-198%

Garrett Motion Inc.GTX

$112M+100%

Simon Property GroupSPG

-$57.42M-63.6%

PaccarPCAR

$279.1M+20.9%

UFP TechnologiesUFPT

$15.71M+76.5%

Other financials

Income statement

Revenue$880.0M+0.1%

Gross profit$427.0M-8.4%

Operating income-$35.0M-156%

Net income-$10.0M-150%

EPS (diluted)-$0.05-150%

Balance sheet

Cash & equivalents$190.0M-52.3%

Total debt$2.3B-3.8%

Total equity$1.3B-34.4%

Total assets$5.2B-13.6%

Cash flow

Operating cash flow$40.0M+471%

CapEx$52.0M+174%

Free cash flow-$12.0M0.0%

Valuation

Market cap$2.11B-22.1%

Profitability

Gross margin48.9%-2.6pp

Operating margin-14.1%-3.9pp

Net margin-17.1%-3.9pp

FCF margin2.8%-4.6pp

Returns & leverage

Return on equity-37.7%+4.0pp

Debt / equity1.8×+0.6×

Current ratio1.5×+0.4×

Where this comes from

Reported directly by DENTSPLY SIRONA in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable.

The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DENTSPLY SIRONA's increase (decrease) in accounts and notes receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is DENTSPLY SIRONA's increase (decrease) in accounts and notes receivable?: DENTSPLY SIRONA (XRAY) reported increase (decrease) in accounts and notes receivable of -$60M in Q1 2026.
How has DENTSPLY SIRONA's increase (decrease) in accounts and notes receivable changed year-over-year?: DENTSPLY SIRONA's increase (decrease) in accounts and notes receivable decreased by 293.5% year-over-year, from $31M to -$60M.